Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker

Figure 3

CDK1 mutation landscape. (a) The CDK1 mutation frequency in multiple TCGA pan-cancer studies according to the cBioPortal database. (b) Mutation diagram of CDK1 in different cancer types across protein domains. (c) Illustration of the three-dimensional structure of the CDK1 protein (containing the R275 mutation site). (d) Correlation between CDK1 gene expression and TCGA tumor mutation load (TMB). (e) Correlation between CDK1 gene expression and TCGA tumor microsatellite instability (MSI).

(a)

(b)

(c)

(d)

(e)